Webinar: Diabetic PN with Rodica Pop Busui, MD, PhD
Demystifying Diabetic Peripheral Neuropathy with Rodica Pop Busui, MD, PhD
Nerve damage caused by diabetes, a condition called diabetic peripheral neuropathy (DPN), is a common and debilitating complication that most often affects the extremities. Patients with diabetic peripheral neuropathy often develop painful symptoms which is known as painful diabetic peripheral neuropathy or diabetic nerve pain.
Diabetic nerve pain can be an extremely challenging condition to diagnose, treat and manage effectively, and the excruciating pain patients may experience has a significant impact on their quality of life.
This webinar is designed to help patients recognize key symptoms associated with diabetic nerve pain of the feet (achiness, throbbing, burning sensations, etc.) and serve as a foundation to help empower patients to speak with their healthcare providers – fostering more productive conversations around diagnosis, disease management and potential solutions for painful diabetic neuropathy.
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome Rodica Pop-Busui, MD, PhD, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, as well as diabetic foot complications, diabetic kidney disease and cardiovascular disease, and the design and conduct of traditional and pragmatic clinical trials for patients with diabetes.
Webinar generously sponsored by Averitas Pharma and held live on Wednesday, September 7, 2022.
From Our Blog...
Research Study for Painful Diabetic Peripheral Neuropathy
Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy.
Clinical Trial for Diabetic Peripheral Neuropathy
Northwestern University is conducting a Phase III clinical trial with Viromed Pharmaceuticals for an investigational drug (VM202) on painful, diabetic peripheral neuropathy in the legs
Treating Painful Diabetic Peripheral Neuropathy: An Update
Summary of journal article reviewing the current state of diabetic peripheral neuropathy treatment: Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes
Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial
VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3
Small Nerve Fibers Defy Neuropathy Conventions
Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in
FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve
On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral